RoMEA Point-of-Care Testing (POCT) Market to 2032
Overview
The RoMEA Point-of-Care Testing (POCT) Market is expected to reach a 395.29 USD Million by 2032 and is projected to grow at a CAGR of 9.36% from 2025 to 2032.
Revenue, 2024 (USD Million)
193.87
Forecast, 2032 (USD Million)
395.29
CAGR, 2024 - 2032
9.36%
Report Coverage
RoMEA
RoMEA Point-of-Care Testing (POCT) Market 2018-2032 USD Million
RoMEA Point-of-Care Testing (POCT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 193.87 USD Million
- Projected Market Size (2032): 395.29 USD Million
- CAGR (2025-2032): 9.36%
Key Findings of RoMEA Point-of-Care Testing (POCT) Market
- The RoMEA Point-of-Care Testing (POCT) Market was valued at 193.87 USD Million in 2024.
- The RoMEA Point-of-Care Testing (POCT) Market is likely to grow at a CAGR of 9.36% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment OTC Testing in Prescription Mode Segment accounted for the largest share of the market with a revenue of 114.36 USD Million
- The fastest growing segment Immunoassays in Platform Segment grew Fastest with a CAGR of 10.16% during the forecast period from 2024 to 2032.
RoMEA Point-of-Care Testing (POCT) Market Scope
RoMEA Point-of-Care Testing (POCT) Market Segmentation & Scope
Product Type
- Others
- Fecal Occult Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Drugs-Of-Abuse (DOA) Testing Products
- Coagulation Monitoring Products
- Haematology Testing Products
- Pregnancy and Fertility Testing Products
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Glucose Monitoring Products
Platform
- Others
- Hematology
- Microfluidics
- Clinical Chemistry Assays
- Molecular Diagnostics
- Dipsticks
- Immunoassays
- Lateral Flow Assays/Immunochromatography Tests
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Pathology Labs
- Diagnostic Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
Prescription Mode
- Prescription-Based Testing
- OTC Testing
Application
- Whole Blood Analysis
- Non- Invasive PCO2 Monitoring
- Blood Transfusion
- Non- Invasive SpO2 Monitoring
- Haematology
- Coagulation
- Others
- Cardiac Monitoring
- Vital Sign Monitoring
- Infectious Diseases
- Blood Glucose
RoMEA Point-of-Care Testing (POCT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 193.87 USD Million |
| Market Value in 2032 | 395.29 USD Million |
| CAGR (2025-2032) | 9.36% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Platform,End User,Distribution Channel,Prescription Mode,Application |
Regional Insights:
-
Leading Market (2024-2032): RoMEA, leading in terms of revenue 193.87 USD Million in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 193.87 USD Million in 2024.
Segments and Scope
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By Product Type
- Glucose Monitoring Products is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 83.63 USD Million in the year 2024.
- Glucose Monitoring Products is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 9.96 % in forecast period 2025-2032.
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By Platform
- Lateral Flow Assays/Immunochromatography Tests is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 83.40 USD Million in the year 2024.
- Immunoassays is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 10.14 % in forecast period 2025-2032.
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By End User
- Hospitals is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 76.43 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 9.80 % in forecast period 2025-2032.
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 97.02 USD Million in the year 2024.
- Online Sales is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 9.01 % in forecast period 2025-2032.
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By Prescription Mode
- OTC Testing is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 114.36 USD Million in the year 2024.
- OTC Testing is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 9.50 % in forecast period 2025-2032.
-
RoMEA Point-of-Care Testing (POCT) Market to 2032, By Application
- Blood Glucose is the largest segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a revenue of 83.63 USD Million in the year 2024.
- Blood Glucose is the Fastest growing segment in RoMEA Point-of-Care Testing (POCT) Market to 2032 with a Growth rate of 9.96 % in forecast period 2025-2032.
RoMEA Point-of-Care Testing (POCT) Market Company Share Analysis
| Company Name |
|
||
| Sinocare | |||
| Abbott | |||
| Hologic, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
RoMEA Point-of-Care Testing (POCT) Market Geographical Sales Distribution, 2018-2032 USD Million
RoMEA Point-of-Care Testing (POCT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoMEA Point-of-Care Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,End User,Distribution Channel,Prescription Mode,Application .
RoMEA Point-of-Care Testing (POCT) Market was valued at USD 193.87(Revenue in USD Million) in 2024.
RoMEA Point-of-Care Testing (POCT) Market is projected to grow at a CAGR of 9.36% during the forecast period of 2024 to 2032.
The OTC Testing segment is expected to dominate the RoMEA Point-of-Care Testing (POCT) Market, holding a largest market share of 114.36 USD Million in 2024
Coming Soon....
RoMEA Point-of-Care Testing (POCT) Market Scope
RoMEA Point-of-Care Testing (POCT) Market Segmentation & Scope
Product Type
- Others
- Fecal Occult Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Drugs-Of-Abuse (DOA) Testing Products
- Coagulation Monitoring Products
- Haematology Testing Products
- Pregnancy and Fertility Testing Products
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Glucose Monitoring Products
Platform
- Others
- Hematology
- Microfluidics
- Clinical Chemistry Assays
- Molecular Diagnostics
- Dipsticks
- Immunoassays
- Lateral Flow Assays/Immunochromatography Tests
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Pathology Labs
- Diagnostic Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
Prescription Mode
- Prescription-Based Testing
- OTC Testing
Application
- Whole Blood Analysis
- Non- Invasive PCO2 Monitoring
- Blood Transfusion
- Non- Invasive SpO2 Monitoring
- Haematology
- Coagulation
- Others
- Cardiac Monitoring
- Vital Sign Monitoring
- Infectious Diseases
- Blood Glucose
Frequently Asked Questions
The RoMEA Point-of-Care Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,End User,Distribution Channel,Prescription Mode,Application .
RoMEA Point-of-Care Testing (POCT) Market was valued at USD 193.87(Revenue in USD Million) in 2024.
RoMEA Point-of-Care Testing (POCT) Market is projected to grow at a CAGR of 9.36% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Point-of-Care Testing (POCT) Market for final year is USD 395.29 (USD Million).
RoMEA Point-of-Care Testing (POCT) Market Company Profiling
Frequently Asked Questions
The RoMEA Point-of-Care Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,End User,Distribution Channel,Prescription Mode,Application .
RoMEA Point-of-Care Testing (POCT) Market was valued at USD 193.87(Revenue in USD Million) in 2024.
RoMEA Point-of-Care Testing (POCT) Market is projected to grow at a CAGR of 9.36% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Point-of-Care Testing (POCT) Market for final year is USD 395.29 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.